Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed Nov 8, 2023. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 76
- −14 vs. Q4 2021
- Portfolio value
- $1.09B
- −$115.0M (−9.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CYHCommunity Health Systems Inc | COM | 7,126,711 | $84.6M | 7.8% | +737,173+11.5% | Added | History |
| BHVNBiohaven Ltd. | COM | 644,666 | $76.4M | 7.0% | +329,537+104.6% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 609,939 | $64.2M | 5.9% | −223,811−26.8% | Reduced | History |
| GSKGSK plc | SPONSORED ADR | 1,259,162 | $55.5M | 5.1% | +691,957+122.0% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 292,234 | $52.4M | 4.8% | −99,686−25.4% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 745,263 | $49.4M | 4.6% | −203,961−21.5% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 417,172 | $49.0M | 4.5% | +13,494+3.3% | Added | History |
| DHRDanaher Corp | Stock | 159,768 | $46.9M | 4.3% | −10,285−6.0% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 4,143,602 | $38.9M | 3.6% | +1,842,104+80.0% | Added | History |
| RCMR1 RCM Holdco Inc. | COM | 1,361,506 | $36.4M | 3.4% | +628,374+85.7% | Added | History |
| AVTRAvantor, Inc. | COM | 995,232 | $33.7M | 3.1% | −130,233−11.6% | Reduced | History |
| MASIMasimo Corp | COM | 208,970 | $30.4M | 2.8% | +208,970 | New | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 8,980,145 | $29.5M | 2.7% | −1,593,157−15.1% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 111,440 | $27.9M | 2.6% | +62,346+127.0% | Added | History |
| NVSTEnvista Holdings Corp | COM | 569,351 | $27.7M | 2.6% | −279,947−33.0% | Reduced | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 5,491,497 | $22.9M | 2.1% | −949,075−14.7% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 636,453 | $21.7M | 2.0% | +43,975+7.4% | Added | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 470,506 | $21.6M | 2.0% | −193,978−29.2% | Reduced | – |
| FATEFate Therapeutics Inc | COM | 456,059 | $17.7M | 1.6% | +201,269+79.0% | Added | History |
| BIIBBiogen Inc. | COM | 78,003 | $16.4M | 1.5% | +44,962+136.1% | Added | History |
| MCKMcKesson Corp | Stock | 52,375 | $16.1M | 1.5% | −83,736−61.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 32,451 | $15.9M | 1.5% | −1,843−5.4% | Reduced | History |
| DXCMDexcom Inc | COM | 28,404 | $14.5M | 1.3% | +22,003+343.7% | Added | History |
| GHGuardant Health, Inc. | COM | 213,203 | $14.1M | 1.3% | +112,869+112.5% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 59,570 | $13.8M | 1.3% | +34,952+142.0% | Added | History |
| ILMNIllumina, Inc. | COM | 38,759 | $13.5M | 1.2% | +38,759 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 410,021 | $12.5M | 1.2% | +200,502+95.7% | Added | History |
| ICLRIcon PLC | COM | 46,816 | $11.4M | 1.0% | −5,051−9.7% | Reduced | History |
| CNCCentene Corp | Stock | 119,170 | $10.0M | 0.9% | −105,443−46.9% | Reduced | History |
| LHLabcorp Holdings Inc. | COM NEW | 37,910 | $10.0M | 0.9% | −7,612−16.7% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 1,377,490 | $9.89M | 0.9% | −70,408−4.9% | Reduced | History |
| NSTGNS Wind Down Co., Inc. | COM | 280,695 | $9.75M | 0.9% | +15,000+5.6% | Added | History |
| HQYHealthequity, Inc. | COM | 144,140 | $9.72M | 0.9% | −189,212−56.8% | Reduced | History |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 220,286 | $9.53M | 0.9% | +39,135+21.6% | Added | – |
| QGENQiagen N.V. | SHS NEW | 192,699 | $9.44M | 0.9% | +30,165+18.6% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 52,871 | $8.63M | 0.8% | −17,369−24.7% | Reduced | History |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 445,059 | $8.30M | 0.8% | −441,081−49.8% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 23,142 | $7.30M | 0.7% | +1,646+7.7% | Added | History |
| RGENRepligen Corp | COM | 36,521 | $6.87M | 0.6% | +31,937+696.7% | Added | History |
| SYNHSyneos Health, Inc. | CL A | 81,416 | $6.59M | 0.6% | −4,196−4.9% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 158,806 | $5.88M | 0.5% | −225,983−58.7% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 100,187 | $4.62M | 0.4% | +37,024+58.6% | Added | History |
| EXELExelixis, Inc. | COM | 203,156 | $4.61M | 0.4% | −332,544−62.1% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 27,047 | $4.26M | 0.4% | −46,122−63.0% | Reduced | History |
| MASS908 Devices Inc. | COM | 217,149 | $4.13M | 0.4% | +217,149 | New | History |
| PBYIPuma Biotechnology, Inc. | COM | 1,424,650 | $4.10M | 0.4% | +306,752+27.4% | Added | History |
| GOSSGossamer Bio, Inc. | COM | 374,723 | $3.25M | 0.3% | +334,813+838.9% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 155,743 | $2.88M | 0.3% | −38,846−20.0% | Reduced | History |
| ANABAnaptysbio, Inc | COM | 114,165 | $2.82M | 0.3% | −68,447−37.5% | Reduced | History |
| Radius Health, Inc.750469207 | COM NEW | 302,172 | $2.67M | 0.2% | +302,172 | New | – |
| WHWKWhitehawk Therapeutics, Inc. | COM | 150,817 | $2.56M | 0.2% | +150,817 | New | History |
| AAgilent Technologies, Inc. | COM | 19,255 | $2.55M | 0.2% | −176−0.9% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 8,163 | $2.46M | 0.2% | −1,662−16.9% | Reduced | History |
| MRUSMerus N.V. | COM | 76,849 | $2.03M | 0.2% | +57,849+304.5% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 15,934 | $2.02M | 0.2% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 9,483 | $1.99M | 0.2% | −9,973−51.3% | Reduced | History |
| RVTYRevvity, Inc. | COM | 9,788 | $1.71M | 0.2% | −21,081−68.3% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 371,540 | $1.55M | 0.1% | −30,000−7.5% | Reduced | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 147,165 | $944.8K | 0.1% | 00.0% | Unchanged | History |
| ENSGEnsign Group, Inc | COM | 10,397 | $936.4K | 0.1% | 00.0% | Unchanged | History |
| HSKAHeska Corp | COM RESTRC NEW | 5,836 | $807.0K | 0.1% | +1,311+29.0% | Added | History |
| KODKodiak Sciences Inc. | COM | 91,200 | $704.1K | 0.1% | +91,200 | New | History |
| ASMBAssembly Biosciences, Inc. | COM | 280,000 | $576.8K | 0.1% | −30,000−9.7% | Reduced | History |
| SPROSpero Therapeutics, Inc. | COM | 59,639 | $518.9K | <0.1% | +59,639 | New | History |
| SNDASonida Senior Living, Inc. | COM | 15,209 | $503.9K | <0.1% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 124,589 | $498.4K | <0.1% | −28,791−18.8% | Reduced | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 237,086 | $488.4K | <0.1% | −111,630−32.0% | Reduced | History |
| SRGASurgalign Holdings, Inc. | COM | 1,573,802 | $478.9K | <0.1% | −344,941−18.0% | Reduced | History |
| TECHBIO-TECHNE Corp | COM | 1,062 | $459.9K | <0.1% | +1,062 | New | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 114,008 | $449.2K | <0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 370,170 | $414.6K | <0.1% | +110,700+42.7% | Added | History |
| KRSAKorsana Biosciences, Inc. | COM | 371,955 | $412.9K | <0.1% | 00.0% | Unchanged | History |
| TECXTectonic Therapeutic, Inc. | COM | 295,369 | $389.9K | <0.1% | −9,620−3.2% | Reduced | History |
| ORTXOrchard Therapeutics plc | ADS | 419,581 | $298.7K | <0.1% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 100,579 | $114.7K | <0.1% | +579+0.6% | Added | History |
| CLVSClovis Oncology, Inc. | COM | 30,000 | $60.6K | <0.1% | +30,000 | New | History |
Options (10)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| GSKGSK plc | SPONSORED ADR | – | $67.7M |
| Invesco QQQ Trust Series I46090E103 | ETF | $65.3M | – |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $38.0M |
| BIIBBiogen Inc. | COM | – | $29.5M |
| iShares Inc46434G772 | MSCI TAIWAN ETF | $6.14M | – |
| MRKMerck & Co., Inc. | Stock | – | $4.00M |
| PGNYProgyny, Inc. | COM | $2.57M | – |
| KODKodiak Sciences Inc. | COM | $1.40M | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $872.3K |
| iShares Russell 2000 Growth ETF464287648 | ETF | $434.8K | – |
Sold out since Q4 2021 (23)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| HUMHumana Inc | Stock | 27,382 | $12.7M | 1.1% | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 231,787 | $12.1M | 1.0% | History |
| ARK Innovation ETF00214Q104 | ETF | 119,118 | $11.3M | 0.9% | – |
| MGLNMagellan Health Inc | COM NEW | 104,700 | $9.95M | 0.8% | History |
| NTRANatera, Inc. | COM | 102,071 | $9.53M | 0.8% | History |
| ZGNXZogenix, Inc. | COM NEW | 550,966 | $8.95M | 0.7% | History |
| PODDInsulet Corp | Stock | 30,172 | $8.03M | 0.7% | History |
| CERNCERNER Corp | COM | 77,543 | $7.22M | 0.6% | History |
| SIBNSI-BONE, Inc. | COM | 258,094 | $5.73M | 0.5% | History |
| NVRONevro Corp | COM | 66,074 | $5.36M | 0.4% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 201,384 | $4.61M | 0.4% | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 87,795 | $3.68M | 0.3% | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 797,694 | $3.14M | 0.3% | History |
| Curevac N VN2451R105 | COM | 85,017 | $2.92M | 0.2% | – |
| GRTSGritstone bio, Inc. | COM | 170,125 | $2.19M | 0.2% | History |
| MRTXMirati Therapeutics, Inc. | COM | 14,840 | $2.18M | 0.2% | History |
| SNYSanofi | SPONSORED ADR | 38,672 | $1.94M | 0.2% | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 25,137 | $1.70M | 0.1% | History |
| MYOMyomo, Inc. | COM NEW | 150,000 | $1.03M | 0.1% | History |
| VCRAVocera Communications, Inc. | COM | 14,970 | $970.7K | 0.1% | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 291,101 | $672.4K | 0.1% | – |
| BKDBrookdale Senior Living Inc. | COM | 79,146 | $408.4K | <0.1% | History |
| FSTXF-star Therapeutics, Inc. | COM | 49,933 | $250.7K | <0.1% | History |